Strangely enough, for a group of data-driven tech entrepreneurs, we’re incredibly good at ignoring similar signs in our own businesses. We’ve created a software that we believe is somehow the world’s next wonder drug, and we just keep selling it to the public. We’ll ignore massive issues—in this case, churn—and just try to sell more of our wonder drug. All the while, our customers will grow resistant to our incredible platform, and we’ll just keep selling more and more, hoping the downstream problems will go away.
